Sanofi to Acquire Tidal Therapeutics for ~$470M

 Sanofi to Acquire Tidal Therapeutics for ~$470M

Sanofi to Acquire Tidal Therapeutics for ~$470M

Shots:

  • Sanofi to acquire Tidal Therapeutics for $160M up front and ~ $310M following the achievement of certain milestones
  • The acquisition will add Tidal’s innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas
  • With its acquisition, Sanofi will further develop the technology platform to expand its research capabilities in immuno-oncology and inflammatory diseases. The technology platform has the potential to bring CAR-T cell therapy to a broader population

Click here to­ read full press release/ article | Ref: GlobeNewswire | Image: MedCity News

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post